These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 10396685

  • 1. [Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J, Shibano T, Satou S, Inoue M, Kobayashi I, Takahashi A, Yomoda S, Nishino T, Oguri T, Watanabe N, Uehara N, Kumasaka K, Yoshida H, Imafuku Y, Kobayasi Y, Okada J, Tokuda K, Hirata Y, Nakasaki N, Hongo T, Kawaguchi R, Ohtaki Y, Sasaki T, Matsumoto N, Saeki H.
    Jpn J Antibiot; 1999 Apr; 52(4):279-91. PubMed ID: 10396685
    [Abstract] [Full Text] [Related]

  • 2. [Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J, Inoue M, Nishino T, Watanabe N, Uehara N, Yoshida H, Imafuku Y, Shibano T, Satou S, Kobayashi I, Takahashi A, Yomoda S, Oguri T, Kumasaka K, Okada J, Hirata Y, Uchida K, Kawaguchi R, Ohtaki Y, Ishigo S, Okamoto E, Murakami E, Matsuoka K, Tokuda K, Saeki H.
    Jpn J Antibiot; 1997 Aug; 50(8):683-703. PubMed ID: 9339395
    [Abstract] [Full Text] [Related]

  • 3. [Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
    Igari J, Inoue M, Nishino T, Watanabe N, Uehara N, Yoshida H, Imafuku Y, Shibano T, Satou S, Kobayashi I, Takahashi A, Yomoda S, Oguri T, Kumasaka K, Kobayasi Y, Okada J, Hirata Y, Nakasaki N, Kawaguchi R, Ohtaki Y, Ishigo S, Okamoto E, Murakami E, Matsuoka K, Saeki H.
    Jpn J Antibiot; 1998 Feb; 51(2):47-68. PubMed ID: 9575436
    [Abstract] [Full Text] [Related]

  • 4. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
    Abe T, Fukuoka T, Sato Y, Ito K, Sei M.
    Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
    Suzuki Y, Nishinari C, Endo H, Tamura C, Jinbo K, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2002 Apr; 55(2):154-80. PubMed ID: 12071094
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
    Ueda Y, Kanazawa K, Eguchi K, Takemoto K, Eriguchi Y, Sunagawa M.
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Lascols C, Legrand P, Mérens A, Leclercq R, Armand-Lefevre L, Drugeon HB, Kitzis MD, Muller-Serieys C, Reverdy ME, Roussel-Delvallez M, Moubareck C, Lemire A, Miara A, Gjoklaj M, Soussy CJ.
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):475-82. PubMed ID: 21088861
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W, Focht J, Nösner K.
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [Abstract] [Full Text] [Related]

  • 17. [Nationwide survey on susceptibilities of clinical isolates to antibacterial agents in 1991].
    Tabe Y, Igari J.
    Jpn J Antibiot; 1995 Mar; 48(3):409-20. PubMed ID: 7752454
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
    Kiratisin P, Keel RA, Nicolau DP.
    Int J Antimicrob Agents; 2013 Jan; 41(1):47-51. PubMed ID: 23127484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.